---
figid: PMC8957335__OTT-15-291-g0003
figtitle: Research Progress of Bufalin in the Treatment of Hepatocellular Carcinoma
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC8957335
filename: OTT-15-291-g0003.jpg
figlink: /pmc/articles/PMC8957335/figure/f0003/
number: F3
caption: Schematic illustration of the mechanism by which bufalin augments sorafenib-induced
  inhibition of angiogenesis through the mTOR/VEGF signaling pathway in HCC.
papertitle: The Research Progress of Bufalin in the Treatment of Hepatocellular Carcinoma.
reftext: Han-yu Jiang, et al. Onco Targets Ther. 2022;15:291-298.
year: '2022'
doi: 10.2147/OTT.S333233
journal_title: OncoTargets and therapy
journal_nlm_ta: Onco Targets Ther
publisher_name: Dove
keywords: bufalin | cancer | therapy | signaling pathways | immunotherapy effect
automl_pathway: 0.9261156
figid_alias: PMC8957335__F3
figtype: Figure
redirect_from: /figures/PMC8957335__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8957335__OTT-15-291-g0003.html
  '@type': Dataset
  description: Schematic illustration of the mechanism by which bufalin augments sorafenib-induced
    inhibition of angiogenesis through the mTOR/VEGF signaling pathway in HCC.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Akt
  - Mtor
  - Tor
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Pvf1
  - Pvf2
  - Pvf3
  - Pvr
  - AKT1
  - AKT2
  - AKT3
  - MTOR
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - PGF
  - KDR
  - FLT1
  - FLT4
---
